ADIPOQ and Obesity: In humans, downregulation of serum AdipoQ can be associated with clinical cases of obesity (23), type 2 diabetes (24), cardiovascular disease (25), Alzheimer’s disease (26) and different types of cancer (e.g., breast cancer) (9).